Linked Life Data

19545692

Source:http://linkedlifedata.com/resource/pubmed/id/19545692

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-6-23
pubmed:abstractText
Aristolochic acid nephropathy (AAN) is a progressive renal interstitial fibrosis disease that was initially reported among a Belgian cohort of about 50 patients after the intake of diet pills containing the Chinese herb Aristolochia fangchi. In addition to renal disease, foci of AAN show increased incidences of urothelial carcinomas (UC). Immunosuppression is associated with an increased risk for the development of different malignancies. Our aim was to examine the outcomes of UC among patients with AAN after transplantation in China, the cradle of this traditional medicine.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1873-2623
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1619-23
pubmed:dateRevised
2011-7-21
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
pubmed:affiliation
Organ Transplantation Center, the Second Affiliated Hospital, Chinese People's Liberation Army General Hospital, Beijing, China.
pubmed:publicationType
Journal Article, Retracted Publication